Viveve Medical (NASDAQ: VIVE) reported Q2 EPS of ($0.54), $0.11 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $3.24 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.